Aurora Cannabis’ Plan To Restructure and Actually Turn A Profit Is Underway

Aurora Cannabis’ Plan To Restructure and Actually Turn A Profit Is Underway Earlier this week, Aurora Cannabis Inc. (ACB.TO) (ACB) issued a progress update on its business transformation plan and the announcement included a number of developments caught our attention. The Canadian cannabis producer has been in the middle of a transformation and is highly focused on cutting costs and improving efficiencies. The market has not responded too favorably to the recent developments and we will monitor how the company continues to execute on this strategy. As part of the transformation, Aurora Cannabis has undertaken a strategic realignment of its operations to protect its position as a leader in key cannabis markets. Through this initiative, the company expects to generate positive cash flow

Aurora Cannabis Provides Key Updates on Business Transformation Plan

Aurora Cannabis Provides Key Updates on Business Transformation Plan Aurora Cannabis Inc. (the “Company” or “Aurora“) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today provided a progress update on its Business Transformation Plan that was previously communicated February 6, 2020. “Across our organization we continue to take decisive action and execute on our previously announced Business Transformation Plan,” stated Michael Singer, Executive Chairman and Interim CEO of Aurora. “With today’s announcement we have achieved our stated SG&A run-rate target and expect to operate at approximately $42 million for the first quarter of fiscal 2021. The further cost savings and margin improvement to be realized from our facility rationalization plan is another example of our commitment to

MediPharm Labs Australia Enters Into New Supply Agreement With VIVO Cannabis and Prepares to Commence Sales

MediPharm Labs Australia Enters Into New Supply Agreement With VIVO Cannabis and Prepares to Commence SalesMediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced that its subsidiary, MediPharm Labs Australia Pty. Ltd. has entered into an agreement to supply pharmaceutical-quality (GMP certified), formulated cannabis oil products to Beacon Medical Australia Pty. Ltd., a subsidiary of VIVO Cannabis Inc. (TSX: VIVO, OTCQX: VVCIF). Under the agreement with Beacon Medical Australia, which has an initial one-year term subject to renewal, MediPharm Labs Australia will supply a full range of GMP-certified, formulated CBD and THC cannabis oil products to Beacon Medical Australia for further distribution under its own branding. “Just weeks after

Its Time To Sink or Swim For Hexo Corp.

Its Time To Sink or Swim For Hexo Corp. During the last month, HEXO Corp. (HEXO.TO (HEXO) reported a number of significant developments centered on reducing expenses and strengthening its balance sheet. These developments come at a crucial time for the Canadian cannabis producer and we believe that our readers need to be aware of this. 2020 has been a challenging year for HEXO and the company could find itself de-listed from the Nasdaq as the shares are trading below the $1 level. If the shares cannot break above this level, HEXO could be forced to conduct a reverse stock split that would result in a higher stock price and fewer shares outstanding. HEXO has recently been trading in a volatile pattern

ISW Holdings Inc (OTCMKTS:ISWH) Lines Up Diverse Tailwinds Following Recent Key Catalysts

ISW Holdings Inc (OTCMKTS:ISWH) Lines Up Diverse Tailwinds Following Recent Key CatalystsISW Holdings Inc (OTCMKTS:ISWH) is a new flavor in the cryptocurrency space, with strong diversification across a number of industries, including the CBD and wellness space. The company is one of the few publicly traded securities that offers exposure to both the CBD and Crypto themes simultaneously. The company is also heavily involved in the logistics and supply chain management space through its joint venture project called “Volum”. ISW Holdings also has appreciable exposure to the renewable energy marketplace, which ties in with its crypto exposure. In other words, this is an interesting small cap (trading at under $0.30/share) with a very diversified footprint. But our focus here is on the

Why NUGS is Interesting in the US Small-Cap Cannabis Growth Space

Why NUGS is Interesting in the US Small-Cap Cannabis Growth SpaceAs the cannabis space continues to heal following the sector’s capitulatory cycle lows hit in March of this year after a devastating two-year bear market, the leadership that appears to be emerging among pot stocks suggests a growing bias toward US cannabis companies. The evidence for this thesis abounds, with the likes of Curaleaf Holdings Inc (OTCMKTS:CURLF), Green Thumb Industries Inc (OTCMKTS:GTBIF), and Cresco Labs Inc (OTCMKTS:CRLBF) sharply outperforming the big Canadian names like Aurora Cannabis Inc (NYSE:ACB), Canopy Growth Corp (NYSE:CGC), and Tilray Inc (NASDAQ:TLRY) since the March lows. That begs the question: where should one look for new small-cap growth opportunities in the space? We would start that search with a

Namaste Technologies Provides Choklat Update

Namaste Technologies Provides Choklat UpdateNamaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF), an online platform for cannabis products, accessories, and responsible education, today announced that Mr. Meni Morim has resigned as a director of Choklat Inc. (“Choklat”), a private company in which Namaste holds a 49% equity interest. Pursuant to its initial investment in the company in March 2019, Namaste was granted the right to appoint a director to the board of Choklat. Mr. Morim resigned due to disagreements between Mr. Morim and management of Choklat. While Namaste retains the right to appoint a director to the board of Choklat to replace Mr. Morim, Namaste has elected not to exercise such right at this time. Additionally, Namaste’s

Missouri’s First Medical Cannabis Cultivation Facility Begins Operations

Missouri’s First Medical Cannabis Cultivation Facility Begins OperationsAs prices for cannabidiol (CBD) continue sinking from 2019, industry participants are pointing to a lack of regulations, both locally and federally, as a major hindrance to the industry’s advancement.In New York, the New York Cannabis Growers & Processors Association (NYCGPA) is pushing for the state department of health to create regulations that would create a legal framework for hemp growers and CBD businesses.The NYCGPA says Gov. Andrew Cuomo signed legislation regulating hemp that took effect on May 1 and empowered the New York State Department of Health to create regulations for the industry.“Farmers and processors envisioned regulations that would provide concrete requirements for producing products and accessing the New York market,” NYCGPA

WeedMD Completes Planting Cannabis on its 27-Acre Outdoor Field and Provides Operational Update on CX Industries

WeedMD Completes Planting Cannabis on its 27-Acre Outdoor Field and Provides Operational Update on CX IndustriesWeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, announced today it completed planting more than 18,000 fully-rooted cannabis plants at its 27-acre outdoor field located adjacent to its modern greenhouse in Strathroy, Ontario. As one of only a handful of licensed-producers entering its second year of outdoor operations, WeedMD also confirmed that its CX Industries extraction hub in Aylmer is now fully operational and extracting cannabinoid-rich, indoor and outdoor-harvested biomass into new cannabis formats. The Company is producing vapourization (“vape”) cartridges for initial launch this month to WeedMD and Starseed’s medical channels. Additional details will be released

All Eyes Are On Canadian Cannabis Retail As It Begins To Reopen Post Covid-19

All Eyes Are On Canadian Cannabis Retail As It Begins To Reopen Post Covid-19 So far, the Canadian cannabis retail market has not lived up to expectations and is a vertical that we believe is flying under the radar. Due to COVID-19, the Canadian cannabis retail market has faced significant headwinds and companies that are levered to the vertical have come under heavy pressure. In late May, Canopy Growth (WEED.TO) (CGC) reported quarterly financial results that missed expectations and the business was impacted by the shutting down of its retail stores in mid-March. As concerns about COVID-19 have diminished, there has been a substantial increase in the number of cannabis retail outlets that have re-opened. The re-opening of retail stores should prove to